_The Texas Society of Health-System Pharmacists encourages members to submit original manuscripts and articles for publication consideration. The following provides guidance on procedures and requirements. Each author submitting for publication in the TSHP Journal certifies that the paper(s) follow these guidelines, which are generally in conformance with the Uniform Requirements for Manuscripts. Exceptions to the Uniform Requirements are noted with an asterisk (*). The procedure applies to all manuscripts except letters, book reviews, management consultations, and similar column material.
 
Manuscripts should be submitted electronically to tshp@tshp.org with TSHP Journal Submission as the subject of the e-mail. Each submission requires an electronic Letter of Transmittal with the manuscript. Each submission requires the appropriate copyright, authorship, and publication statements signed by each author and submitted to TSHP, 3000 Joe DiMaggio #30-A, Round Rock, TX 78665-3994 prior to review. Authors are encouraged to suggest manuscript reviewers.
 
Letter of Transmittal

• Two sentence maximum content summary.
• Information related to prior or duplicate publication or submission of any part of the work.
• Name and contact information of corresponding author (phone, fax, e-mail, mailing address).
• Statement of financial or other relationships (e.g. stock ownership, advisory board, speaker’s bureau, honorariums) that may be viewed as creating a conflict of interest.

 
General

• The manuscript is typed single-spaced in a 12-point font through-out (including tables, references, footnotes, figure captions, and author identification) on 8.5 x 11.0-inch paper with margins of at least 1 inch all around. Place one space between paragraphs; do not indent paragraphs.
• Copies of permission to reproduce published material, to use illustrations of identifiable persons, or to name persons for contributions are provided.

 
Title page

• Contains a concise, informative title, author(s) name(s), title(s) and professional designation(s) and no other information.*

 
Abstract

• (Not required for Notes, Drug Experiences, Therapy Consultations, Management Case Studies, Commentaries, Reflections, Letters, Best Practices, and similar column material)

 
Text

• Descriptive headings are used to identify major sections of the paper; subheadings also may be used.
• Level of significance; unusual or complex statistical methods are explained briefly or referenced.
• If more than one statistical test is used, the data evaluated by each test are clearly identified in the Methods section.
• Mean values for study results are accompanied by some measure of variability or precision (e.g., standard deviations); the use of confidence intervals, when appropriate, is encouraged.
• Identifies precisely all drugs and chemicals used by generic name (with salt, if applicable). Trade names are used only to identify that a specific brand of drug was used. For reports of clinical research, identification of drugs as being racemic mixtures or single isomers is encouraged.
• Measurements are reported in the units in which they were made.
• Volume, distance, and weight measurements are expressed in metric units.*
• Every reference, figure, table, and appendix is cited in the text in numerical order. (Order of mention in text determines the number given to each.)
• Footnotes are identified consecutively in the text by superscript, lowercase letters or numbers.

 
References

• Are identified in text, tables, and legends by superscript* Arabic numbers.
• Are typed single {see previous note}-spaced on pages separate from the text and numbered consecutively as they appear in the text under a heading entitled “References.” References that appear in tables or figure captions should receive consecutive numbers based on the placement of the first mention of the table or figure in the text.
• Have been verified by the author(s) against the original documents.

 
Tables

• Are typed single-spaced, each (complete with title and footnotes) on a separate page (not submitted as photographs).
• Use superscript letters for footnote designations.*
• If data from another published or unpublished source are used, permission is obtained from the source (proof submitted with paper), and the source is acknowledged.

 
Figures

• Figures should be supplied in their original native file format, in a separate file, and not embedded in the text. We accept figure files in JPG, PDF, or PageMaker formats,
• Are numbered consecutively as they are cited in the text.
• All abbreviations and symbols used in the figure are defined; when appropriate, the measure of variability or precision represented is identified (e.g., do error bars represent standard deviations or confidence? intervals?).
• If previously published, the original source is acknowledged, and written permission from the copyright holder to reproduce the material is submitted.

 
Flow Diagrams

• The use of flow diagrams and other visual aids to show the disposition of study participants through clinical trials, clarify treatment algorithms, or show relationships among various components of a program or system is encouraged.
• Flow diagrams should be in a separate file, not embedded in the text, and supplied as separate files and in their original native file format such as PowerPoint, PageMaker, PPEG or PDF formats.
• If using flowchart-specific software, export or save the document as Windows Meta File (.wmf).

 
*Adapted from the Procedure for Submissions to the American Journal of Health-System Pharmacy, Updated February 2006)

Click Here to download the Copyright, Authorship, and Publications Statements form.